{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:13:00Z","timestamp":1761901980567,"version":"build-2065373602"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"DOI":"10.7759\/cureus.95801","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:04:09Z","timestamp":1761901449000},"source":"Crossref","is-referenced-by-count":0,"title":["Strategies for the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ): An Umbrella Review"],"prefix":"10.7759","author":[{"given":"Amina","family":"Gharibi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Essadeq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajar","family":"Yamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Al Jalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamila","family":"Kissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx RE","year":"2003","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003, 61:1115-7. 10.1016\/s0278-2391(03)00720-1","journal-title":"J Oral Maxillofac Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update","volume":"72","author":"Ruggiero SL","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg. 2014, 72:1938-56. 10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero SL","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg. 2022, 80:920-43. 10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2016.1177021","article-title":"Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology","volume":"15","author":"Fusco V","year":"2016","unstructured":"Fusco V, Santini D, Armento G, Tonini G, Campisi G. Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology. Expert Opin Drug Saf. 2016, 15:925-35. 10.1080\/14740338.2016.1177021","journal-title":"Expert Opin Drug Saf"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4501-x","article-title":"Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review","volume":"27","author":"Nicolatou-Galitis O","year":"2019","unstructured":"Nicolatou-Galitis O, Kouri M, Papadopoulou E, et al.. Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. Support Care Cancer. 2019, 27:383-94. 10.1007\/s00520-018-4501-x","journal-title":"Support Care Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2018.11.012","article-title":"Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab-a review","volume":"127","author":"King R","year":"2019","unstructured":"King R, Tanna N, Patel V. Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab-a review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019, 127:289-99. 10.1016\/j.oooo.2018.11.012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2019.09.023","article-title":"Osteonecrosis and osteomyelitis of the jaw associated with tumour necrosis factor-alpha (TNF-\u03b1) inhibitors: a systematic review","volume":"58","author":"Sacco R","year":"2020","unstructured":"Sacco R, Shah S, Leeson R, Moraschini V, de Almeida Barros Mour\u00e3o CF, Akintola O, Lalli A. Osteonecrosis and osteomyelitis of the jaw associated with tumour necrosis factor-alpha (TNF-\u03b1) inhibitors: a systematic review. Br J Oral Maxillofac Surg. 2020, 58:25-33. 10.1016\/j.bjoms.2019.09.023","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2020.12.045","article-title":"Factors influencing severity of medication-related osteonecrosis of the jaw: a retrospective study","volume":"79","author":"Feng Z","year":"2021","unstructured":"Feng Z, An J, Zhang Y. Factors influencing severity of medication-related osteonecrosis of the jaw: a retrospective study. J Oral Maxillofac Surg. 2021, 79:1683-8. 10.1016\/j.joms.2020.12.045","journal-title":"J Oral Maxillofac Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2018.08.015","article-title":"Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study","volume":"126","author":"Hallmer F","year":"2018","unstructured":"Hallmer F, Andersson G, G\u00f6trick B, Warfvinge G, Anderud J, Bj\u00f8rnland T. Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018, 126:477-85. 10.1016\/j.oooo.2018.08.015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn554","article-title":"Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid","volume":"20","author":"Dimopoulos MA","year":"2009","unstructured":"Dimopoulos MA, Kastritis E, Bamia C, et al.. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol. 2009, 20:117-20. 10.1093\/annonc\/mdn554","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2684924","article-title":"The dental management of patients at risk of medication-related osteonecrosis of the jaw: new paradigm of primary prevention","volume":"2018","author":"Di Fede O","year":"2018","unstructured":"Di Fede O, Panzarella V, Mauceri R, et al.. The dental management of patients at risk of medication-related osteonecrosis of the jaw: new paradigm of primary prevention. Biomed Res Int. 2018, 2018:2684924. 10.1155\/2018\/2684924","journal-title":"Biomed Res Int"},{"key":"ref12","article-title":"Diagnosis and treatment of medication-related osteonecrosis of the jaws from an oncologist's perspectives [Article in Chinese]","volume":"56","author":"Yuan P","year":"2021","unstructured":"Yuan P. Diagnosis and treatment of medication-related osteonecrosis of the jaws from an oncologist's perspectives [Article in Chinese]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2021, 56:415-20.","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.20963","article-title":"Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review","volume":"21","author":"Diniz-Freitas M","year":"2016","unstructured":"Diniz-Freitas M, Limeres J. Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review. Med Oral Patol Oral Cir Bucal. 2016, 21:e250-9. 10.4317\/medoral.20963","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2016.05.004","article-title":"Medication-related osteonecrosis of the jaw: is autologous platelet concentrate application effective for prevention and treatment? A\u00a0systematic review","volume":"44","author":"Lopez-Jornet P","year":"2016","unstructured":"Lopez-Jornet P, Sanchez Perez A, Amaral Mendes R, Tobias A. Medication-related osteonecrosis of the jaw: is autologous platelet concentrate application effective for prevention and treatment? A\u00a0systematic review. J Craniomaxillofac Surg. 2016, 44:1067-72. 10.1016\/j.jcms.2016.05.004","journal-title":"J Craniomaxillofac Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2018.08.003","article-title":"Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: a systematic review with meta-analyses","volume":"85","author":"Karna H","year":"2018","unstructured":"Karna H, Gonzalez J, Radia HS, Sedghizadeh PP, Enciso R. Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: a systematic review with meta-analyses. Oral Oncol. 2018, 85:15-23. 10.1016\/j.oraloncology.2018.08.003","journal-title":"Oral Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03795","article-title":"Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review","volume":"6","author":"Ottesen C","year":"2020","unstructured":"Ottesen C, Schiodt M, Gotfredsen K. Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review. Heliyon. 2020, 6:e03795. 10.1016\/j.heliyon.2020.e03795","journal-title":"Heliyon"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.24197","article-title":"Proposal for a preventive protocol for medication-related osteonecrosis of the jaw","volume":"26","author":"Romero-Ruiz MM","year":"2021","unstructured":"Romero-Ruiz MM, Romero-Serrano M, Serrano-Gonz\u00e1lez A, Serrera-Figallo M\u00c1, Guti\u00e9rrez-P\u00e9rez JL, Torres-Lagares D. Proposal for a preventive protocol for medication-related osteonecrosis of the jaw. Med Oral Patol Oral Cir Bucal. 2021, 26:e314-26. 10.4317\/medoral.24197","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0063","article-title":"The prevention of medication-related osteonecrosis of the jaw","volume":"114","author":"Poxleitner P","year":"2017","unstructured":"Poxleitner P, Engelhardt M, Schmelzeisen R, Voss P. The prevention of medication-related osteonecrosis of the jaw. Dtsch Arztebl Int. 2017, 114:63-9. 10.3238\/arztebl.2017.0063","journal-title":"Dtsch Arztebl Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2020.01.014","article-title":"Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review","volume":"48","author":"Fortunato L","year":"2020","unstructured":"Fortunato L, Bennardo F, Buffone C, Giudice A. Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review. J Craniomaxillofac Surg. 2020, 48:268-85. 10.1016\/j.jcms.2020.01.014","journal-title":"J Craniomaxillofac Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2334\/josnusd.21-0016","article-title":"Lack of evidence in reducing risk of MRONJ after teeth extractions with systemic antibiotics","volume":"63","author":"Cabras M","year":"2021","unstructured":"Cabras M, Gambino A, Broccoletti R, Sciascia S, Arduino PG. Lack of evidence in reducing risk of MRONJ after teeth extractions with systemic antibiotics. J Oral Sci. 2021, 63:217-26. 10.2334\/josnusd.21-0016","journal-title":"J Oral Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59050972","article-title":"Laser devices and autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: a systematic review","volume":"59","author":"Scribante A","year":"2023","unstructured":"Scribante A, Ghizzoni M, Pellegrini M, Pulicari F, Spadari F. Laser devices and autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: a systematic review. Medicina (Kaunas). 2023, 59:972. 10.3390\/medicina59050972","journal-title":"Medicina (Kaunas)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.10.015","article-title":"Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature","volume":"51","author":"Del Fabbro M","year":"2015","unstructured":"Del Fabbro M, Gallesio G, Mozzati M. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. Eur J Cancer. 2015, 51:62-74. 10.1016\/j.ejca.2014.10.015","journal-title":"Eur J Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012432.pub2","article-title":"Interventions for managing medication-related osteonecrosis of the jaw","volume":"10","author":"Beth-Tasdogan NH","year":"2017","unstructured":"Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O. Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev. 2017, 10:CD012432. 10.1002\/14651858.CD012432.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417163-strategies-for-the-prevention-of-medication-related-osteonecrosis-of-the-jaw-mronj-an-umbrella-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:04:11Z","timestamp":1761901451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417163-strategies-for-the-prevention-of-medication-related-osteonecrosis-of-the-jaw-mronj-an-umbrella-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.95801","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,31]]}}}